Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disulfiram-induced hepatitis.

S Kahn1, J B Farnum, E Thomas

  • 1Veterans Affairs Medical Center, Medicine Service, Johnson City, TN 37684.

Southern Medical Journal
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The molecular neuron-glia couple and epileptogenesis.

Advances in neurology·1999
Same author

Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N-[[4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines.

The Journal of pharmacy and pharmacology·1999
Same author

Colo-cholecystic fistula: an unusual complication of colonic diverticular disease.

The American journal of gastroenterology·1999
Same author

Clinical usefulness of biochemical resorption markers in osteoporosis.

Annals of clinical biochemistry·1999
Same author

Short-term physical risk factors for new episodes of low back pain. Prospective evidence from the South Manchester Back Pain Study.

Spine·1999
Same author

Oral etoposide for patients with advanced adenocarcinoma of the pancreas.

Investigational new drugs·1999

Disulfiram therapy can cause drug-induced liver injury, presenting with symptoms like fever and rash. Prompt discontinuation of disulfiram leads to recovery of liver function.

Area of Science:

  • Hepatology
  • Clinical Toxicology

Background:

  • Disulfiram is a medication used to deter alcohol consumption.
  • Drug-induced liver injury (DILI) is a significant concern with various medications.

Observation:

  • A patient developed headache, fever, nausea, vomiting, rash, and eosinophilia after three weeks of disulfiram treatment.
  • Liver biopsy revealed low-grade lobular hepatitis.

Findings:

  • Disulfiram-induced hepatitis presented with unique clinical features in this case.
  • Cessation of disulfiram therapy resulted in symptom resolution and normalization of liver function tests.

Implications:

  • This case highlights the importance of considering disulfiram in the differential diagnosis of drug-induced liver injury.

Related Experiment Videos

  • Early recognition and withdrawal of the offending agent are crucial for managing disulfiram hepatotoxicity.